Hopp til innhold
NHI.no
Annonse

Hvordan vet jeg at jeg har insulinresistens?

Innhold i artikkelen

Det finnes ingen enkel prøve som kan si at du har insulinresistens syndrom. Hvis en eller flere av følgende faktorer gjelder for deg, kan legen mistenke at du har insulinresistens syndrom:

Annonse
  • En eller flere av dine søsken eller foreldre har fått diagnosen diabetes type 2
  • Du har hatt diabetes (eller forhøyet blodsukker) under svangerskap
  • Du har fått påvist tilstanden polycystisk ovariesyndrom (PCO)
  • Du har et blodsukkernivå som ikke er høyt nok til å si at du har diabetes, men det er høyere enn normalt. Det betyr at du har økt risiko for å få diabetes
  • Du er overvektig
  • Du har mer fett rundt midjen enn rundt hoftene. Det vil si at om du måler omkretsen, er den større rundt midjen enn rundt hoftene/baken.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Metabolsk syndrom . Referanselisten for dette dokumentet vises nedenfor

  1. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018 Feb 26;20(2):12. PMID: 29480368 PubMed
  2. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-81. PubMed
  3. Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH. Dose-response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia 2015; 58:485. PubMed
  4. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215-225. PMID: 28639538 PubMed
  5. Deen D. Metabolic syndrome: Time for action. Am Fam Physician 2004; 69: 2875-82. PubMed
  6. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome (http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf) (April 14, 2005) (accessed June 10, 2005).
  7. Ilanne-Parikka P, Eriksson JG, Lindström J, et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care. 2008;31:805-807. PubMed
  8. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13-27. PMID: 28604169 PubMed
  9. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438. PubMed
  10. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, Davey Smith G. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD002137. DOI: 10.1002/14651858.CD002137.pub3. DOI
  11. Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No.: CD009217. DOI: 10.1002/14651858.CD009217.pub3. DOI
  12. Szapary PO, Hark LA, Burke FM. The metabolic syndrome: a new focus for lifestyle modification. Patient Care 2002; 36: 75-88. PubMed
  13. Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol 2003; 91(7A): 29E-39E.
  14. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc Med. 2017;2(1):e000143. Published 2017 Mar 1. PMID: 28879026. PubMed
  15. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93. New England Journal of Medicine
  16. Mente A, Yusuf S, Islam S, McQueen MJ, et al. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Cardiol 2010; 55: 2390-8. PubMed
Annonse
Annonse